Literature DB >> 24333724

CD68(+)HLA-DR(+) M1-like macrophages promote motility of HCC cells via NF-κB/FAK pathway.

Hao Wang1, Xianteng Wang1, Xia Li2, Yuchen Fan3, Guosheng Li4, Chun Guo1, Faliang Zhu1, Lining Zhang1, Yongyu Shi5.   

Abstract

TAM is a prominent component of inflammatory microenvironment, presenting M1 and M2 polarized states in HCC. The objective of this study is to investigate the relationship between M1-polarized macrophages and metastasis in HCC. We used immunohistochemical double-staining method to inspect the infiltration of CD68(+)HLA-DR(+) M1-like macrophages in HCC tissues. The M1-polarized macrophage was derived from THP-1 cell treated by LPS and IFN-γ in vitro. Transwell migration assay was used to evaluate whether the M1-polarized macrophage enhanced motility of HCC cells in the presence or absence of NF-κB inhibitor Bay 11-7802. The activation of NF-κB and FAK signaling pathways was examined by Western blot assay. Our results showed that the density of CD68(+)HLA-DR(+) TAM in the HCC with metastasis is significantly higher than that in the HCC without metastasis. Moreover, the conditioned medium from the M1 macrophages promote the migration of HCC cells and induced the activation of NF-κB and FAK signaling. The promoted migration of HCC cells was abrogated by the Bay 11-7802, as well as the activation of NF-κB and FAK pathway. Our findings implied a pro-metastatic role of M1-like TAM in HCC.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  FAK; Hepatocellular carcinoma; NF-κB; Tumor-associated macrophage

Mesh:

Substances:

Year:  2013        PMID: 24333724     DOI: 10.1016/j.canlet.2013.11.013

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  31 in total

Review 1.  The p38/MKP-1 signaling axis in oral cancer: Impact of tumor-associated macrophages.

Authors:  Zhenning Li; Fa-Yu Liu; Keith L Kirkwood
Journal:  Oral Oncol       Date:  2020-02-10       Impact factor: 5.337

Review 2.  SUMOylation and phosphorylation cross-talk in hepatocellular carcinoma.

Authors:  Maria Lauda Tomasi; Komal Ramani
Journal:  Transl Gastroenterol Hepatol       Date:  2018-04-23

Review 3.  Prognostic significance and targeting tumor-associated macrophages in cancer: new insights and future perspectives.

Authors:  Umar Mehraj; Hina Qayoom; Manzoor A Mir
Journal:  Breast Cancer       Date:  2021-03-04       Impact factor: 4.239

4.  Mechanism of HBV-positive liver cancer cell exosomal miR-142-3p by inducing ferroptosis of M1 macrophages to promote liver cancer progression.

Authors:  Zongqiang Hu; Hui Zhang; Wei Liu; Yanfeng Yin; Jie Jiang; Chuntao Yan; Yiting Wang; Li Li
Journal:  Transl Cancer Res       Date:  2022-05       Impact factor: 0.496

Review 5.  Targeting tumor-associated macrophages by anti-tumor Chinese materia medica.

Authors:  Wei-Ling Pu; Li-Kang Sun; Xiu-Mei Gao; Curzio Rüegg; Muriel Cuendet; Micheal O Hottiger; Kun Zhou; Lin Miao; Yun-Sha Zhang; Margaret Gebauer
Journal:  Chin J Integr Med       Date:  2017-10-08       Impact factor: 1.978

6.  Modulation of intestinal microbiota by glycyrrhizic acid prevents high-fat diet-enhanced pre-metastatic niche formation and metastasis.

Authors:  Miao Qiu; Keqing Huang; Yanzhuo Liu; Yuqing Yang; Honglin Tang; Xiaoxiao Liu; Chenlong Wang; Honglei Chen; Yu Xiong; Jing Zhang; Jing Yang
Journal:  Mucosal Immunol       Date:  2019-02-12       Impact factor: 7.313

7.  Computational modeling of malignant ascites reveals CCL5-SDC4 interaction in the immune microenvironment of ovarian cancer.

Authors:  Soochi Kim; Youngjin Han; Se Ik Kim; Juwon Lee; HyunA Jo; Wenyu Wang; Untack Cho; Woong-Yang Park; Thomas A Rando; Danny N Dhanasekaran; Yong Sang Song
Journal:  Mol Carcinog       Date:  2021-03-15       Impact factor: 4.784

Review 8.  The Role of Tumor Microenvironment in Cancer Metastasis: Molecular Mechanisms and Therapeutic Opportunities.

Authors:  Christiana M Neophytou; Myrofora Panagi; Triantafyllos Stylianopoulos; Panagiotis Papageorgis
Journal:  Cancers (Basel)       Date:  2021-04-23       Impact factor: 6.639

Review 9.  Defects in Macrophage Reprogramming in Cancer Therapy: The Negative Impact of PD-L1/PD-1.

Authors:  Hao Cai; Yichi Zhang; Jian Wang; Jinyang Gu
Journal:  Front Immunol       Date:  2021-06-23       Impact factor: 7.561

10.  Small ubiquitin-related modifier 2/3 interacts with p65 and stabilizes it in the cytoplasm in HBV-associated hepatocellular carcinoma.

Authors:  Jun Liu; Manqi Sha; Qianfeng Wang; Yong Ma; Xiaoping Geng; Yufeng Gao; Lijie Feng; Yujun Shen; Yuxian Shen
Journal:  BMC Cancer       Date:  2015-10-12       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.